RA
PHGE icon

Royce & Associates’s BiomX PHGE Stock Holding History

Royce & Associates’s Portfolio PHGE Stock Details PHGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-835
Closed -$54K – 951
2022
Q3 		$54K Sell
835
-895
-52% -$114K ﹤0.01% 919
2022
Q2 		$240K Buy
1,730
+42
+2% +$8.62K ﹤0.01% 901
2022
Q1 		$619K Buy
1,688
+1,126
+200% +$335K 0.01% 857
2021
Q4 		$171K Sell
562
-626
-53% -$250K ﹤0.01% 949
2021
Q3 		$691K Sell
1,188
-701
-37% -$543K 0.01% 861
2021
Q2 		$1.96M Hold
1,889
– – 0.01% 761
2021
Q1 		$2.56M Buy
+1,889
New +$2.55M 0.02% 717

Other funds holding PHGE

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $16.3B AUM 37.67% 1-Year Est. Return